Bruce Pyenson

2.0k total citations
51 papers, 1.4k citations indexed

About

Bruce Pyenson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Bruce Pyenson has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 11 papers in Economics and Econometrics. Recurrent topics in Bruce Pyenson's work include Lung Cancer Diagnosis and Treatment (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Colorectal Cancer Screening and Detection (7 papers). Bruce Pyenson is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Colorectal Cancer Screening and Detection (7 papers). Bruce Pyenson collaborates with scholars based in United States, United Kingdom and Spain. Bruce Pyenson's co-authors include Kathryn Fitch, Kosuke Iwasaki, Stephen R. Connor, Carol Spence, David B. Abrams, Andrea C. Villanti, Barry M. Kinzbrunner, James L. Mulshine, Howard Kahn and Raja M. Flores and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bruce Pyenson

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Pyenson United States 17 514 388 357 201 174 51 1.4k
Ladan Golestaneh United States 22 280 0.5× 161 0.4× 248 0.7× 84 0.4× 60 0.3× 79 2.1k
Lucia C. Petito United States 22 149 0.3× 389 1.0× 139 0.4× 113 0.6× 85 0.5× 76 1.4k
Andrew E. Chapman United States 20 400 0.8× 276 0.7× 623 1.7× 332 1.7× 85 0.5× 63 2.0k
Jonathan Inselman United States 20 138 0.3× 282 0.7× 223 0.6× 129 0.6× 78 0.4× 56 1.4k
Hemalkumar B. Mehta United States 25 341 0.7× 152 0.4× 324 0.9× 151 0.8× 45 0.3× 93 1.7k
Claire Beguin Belgium 23 272 0.5× 179 0.5× 272 0.8× 200 1.0× 40 0.2× 66 1.7k
Diana M. Tisnado United States 21 168 0.3× 596 1.5× 616 1.7× 220 1.1× 40 0.2× 44 1.5k
Kevin McLaughlin Canada 24 207 0.4× 456 1.2× 94 0.3× 199 1.0× 128 0.7× 56 2.0k
Shivan J. Mehta United States 21 348 0.7× 243 0.6× 824 2.3× 250 1.2× 50 0.3× 103 1.8k
Marisa Baré Spain 24 432 0.8× 98 0.3× 649 1.8× 88 0.4× 195 1.1× 92 1.5k

Countries citing papers authored by Bruce Pyenson

Since Specialization
Citations

This map shows the geographic impact of Bruce Pyenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Pyenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Pyenson more than expected).

Fields of papers citing papers by Bruce Pyenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Pyenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Pyenson. The network helps show where Bruce Pyenson may publish in the future.

Co-authorship network of co-authors of Bruce Pyenson

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Pyenson. A scholar is included among the top collaborators of Bruce Pyenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Pyenson. Bruce Pyenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deslée, Gaëtan, et al.. (2025). Impact of Increased Use of Single-Inhaler Triple Therapies on COPD Exacerbation Rates, Mortality, and Total Costs: PROMETHEUS France. International Journal of COPD. Volume 20. 3753–3763.
2.
3.
Pyenson, Bruce, et al.. (2024). EP.04D.01 Claims-Based Yield Metric for Lung Cancer Screening. Journal of Thoracic Oncology. 19(10). S474–S474.
4.
Bhutani, Mohit, Alan Kaplan, Sheena Kayaniyil, et al.. (2024). Implementation of 2023 CTS guidelines for SITT could reduce exacerbation and mortality rates in COPD: PROMETHEUS Canada.. PA1170–PA1170.
5.
Smith, Rebecca, et al.. (2024). We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?. Journal of health economics and outcomes research. 145–153. 2 indexed citations
6.
Fathi, Joelle T., Claudia I. Henschke, Ella A. Kazerooni, et al.. (2024). The American Cancer Society National Lung Cancer Roundtable strategic plan: Implementation of high‐quality lung cancer screening. Cancer. 130(23). 3961–3972. 3 indexed citations
7.
8.
Smith, Rebecca, et al.. (2024). We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?. Journal of health economics and outcomes research. 11(2). 145–153. 3 indexed citations
9.
Martínez, Fernando J., et al.. (2023). PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population. Journal of health economics and outcomes research. 10(1). 20–27. 4 indexed citations
10.
Bazell, Carol, Michael Pollack, Alejandro P. Comellas, et al.. (2022). A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD. International Journal of COPD. Volume 17. 2635–2652. 6 indexed citations
11.
Pyenson, Bruce, et al.. (2019). Applying Machine Learning Techniques to Identify Undiagnosed Patients with Exocrine Pancreatic Insufficiency. Journal of health economics and outcomes research. 32–46.
12.
Pyenson, Bruce, et al.. (2016). 2016 reflections on the favorable cost-benefit of lung cancer screening. Annals of Translational Medicine. 4(8). 155–155. 5 indexed citations
13.
Fitch, Kathryn, et al.. (2015). The value of colonoscopic colorectal cancer screening of adults aged 50 to 64.. PubMed. 21(7). e430–8. 6 indexed citations
14.
Pyenson, Bruce, et al.. (2015). Medicare cost of colorectal cancer screening: CT colonography vs. optical colonoscopy. Abdominal Imaging. 40(8). 2966–2976. 36 indexed citations
15.
Pyenson, Bruce, et al.. (2014). Costs and repeat rates associated with colonoscopy observed in medical claims for commercial and Medicare populations. BMC Health Services Research. 14(1). 92–92. 26 indexed citations
16.
Fitch, Kathryn, Bruce Pyenson, & Kosuke Iwasaki. (2013). Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes. Journal of Managed Care Pharmacy. 19(8). 609–620. 37 indexed citations
17.
Postma, Maarten J., George Milne, E. Anthony S. Nelson, et al.. (2010). Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts. Expert Review of Anti-infective Therapy. 8(12). 1431–1439. 4 indexed citations
18.
Morse, Alan R. & Bruce Pyenson. (2009). Medical Care Cost of Medicare/Medicaid Beneficiaries with Vision Loss. Ophthalmic Epidemiology. 16(1). 50–57. 4 indexed citations
19.
Connor, Stephen R., Bruce Pyenson, Kathryn Fitch, Carol Spence, & Kosuke Iwasaki. (2007). Comparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year Window. Journal of Pain and Symptom Management. 33(3). 238–246. 288 indexed citations
20.
Pyenson, Bruce, Stephen R. Connor, Kathryn Fitch, & Barry M. Kinzbrunner. (2004). Medicare cost in matched hospice and non-hospice cohorts. Journal of Pain and Symptom Management. 28(3). 200–210. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ladan Golestaneh Breakdown of academic impact, for papers by Lucia C. Petito Breakdown of academic impact, for papers by Andrew E. Chapman Breakdown of academic impact, for papers by Jonathan Inselman Breakdown of academic impact, for papers by Hemalkumar B. Mehta Breakdown of academic impact, for papers by Claire Beguin Breakdown of academic impact, for papers by Diana M. Tisnado Breakdown of academic impact, for papers by Kevin McLaughlin Breakdown of academic impact, for papers by Shivan J. Mehta Breakdown of academic impact, for papers by Marisa Baré
Rankless by CCL
2026